 |
||||||||||||||||
| GEM 21S® is indicated to treat periodontally related defects, including:
Following is a representative case with GEM 21S® Growth-factor Enhanced Matrix |
||||||||||||||||
|
Vertical Defect at Baseline Through 24 Months Post-Op Case by: Dr. Michael McGuire |
||||||||||||||||
 |
 |
 |
||||||||||||||
| Important Safety Information. View the Package Insert:  United States Canada - English Canada - FrenchTo view a presentation about GEM 21S®, click here. |
||||||||||||||||
| GEM 21S® in place. | ||||||||||||||||
| Baseline 9 mm probing depth and 8 mm deep by 3 mm wide, 2-wall intrabony defect on the distal of tooth #19. | ||||||||||||||||
 |
||||||||||||||||
| Representative cases from the GEM 21S® pivotal trial: Case 1 Case 2 Case 3 Case 4 Case 5 |
||||||||||||||||
| 6 months post-operative, a 3 mm probing depth is observed. | ||||||||||||||||
 |
 |
 |
||||||||||||||
| Pre-operative radiograph | 6 month post-operative radiograph demonstrating increased radiopacity on the distal surface of the tooth root. | 12 month post-operative radiograph | ||||||||||||||
 |
||||||||||||||||
| 24 month post-operative radiograph demonstrates complete fill of the intrabony defect with a normal bone trabecular pattern. Note the presence of the lamina dura along the distal root. | ||||||||||||||||